Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
37 /100
MEDIUM RISK
Score updated Oct 13, 2026

DMAC — DiaMedica Therapeutics Inc. Dilution Risk Tracker

Track DMAC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DMAC — Get alerts when the score changes →

As of October 13, 2026, DiaMedica Therapeutics Inc. (DMAC) has a DilutionWatch DilutionScore of 37/100, rated MEDIUM dilution risk. DiaMedica Therapeutics Inc. has a market capitalization of $442.19M, 53.93M shares outstanding, 98 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
25
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for DMAC.
🔔 Track DMAC — Get forecast alerts →

Market Data

Market Cap$442.19M
Shares Outstanding53.93M
Float28.60M
Cash$43.50M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore37/100DilutionWatch score record
Shares Outstanding53.93MVerified float table or market cache
Public Float28.60MVerified float table or market cache
Market Cap$442.19MMarket data cache
Cash Runway18.7 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 0.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 9.3% shares (2026Q1 vs prior)
98 institutional holders · 13.52M shares
#1 COOPERMAN LEON G 2.02M shares
#2 BlackRock, Inc. 1.86M shares
#3 MORGAN STANLEY 1.23M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.58M
Days to Cover23.3
% of Float19.5%
FINRA data as of Sep 30, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news available for this ticker.

DilutionScore History — Last 90 Days

DMAC's DilutionScore is currently 37/100 (Medium risk), with 2 score changes tracked over 89 days. The score deteriorated from 40/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202637/100MEDIUM53 days
Aug 14 – Aug 21, 202640/100MEDIUM7 days
Jul 16 – Aug 13, 202645/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

DMAC shares outstanding have increased 0.3% from 53.74M (Apr 2026) to 53.88M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 23, 202653.88M28.60M▲ 0.59%
Apr 03, 202653.88M28.43M▲ 0.51%
Apr 01, 202653.74M28.28M▲ 3.47%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track DMAC Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment DMAC files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking DMAC — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for DMAC
DMAC FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.